DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
In Ramsay Health Care's risky leadership pick, we explained the significance of long-serving chief executive Craig McNally stepping down. His successor, Natalie Davis—who started in October— is an ...
Following last week's Holds as Buys mini-portfolio, this week we're launching an Income mini-income portfolio, in part for the same reasons. We know income-focused members follow our Model Income ...
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
What is the current share price of SAB Biotherapeutics (SABS)? SAB Biotherapeutics's (SABS) current share price is $2.19. This constitutes a price movement of 46.59% when compared to the share price 7 ...
Last year my grandfather went for a walk. His evening stroll was the bedrock of his schedule but, at 98, dementia had set in. Hours later, after frantic searching, he was discovered in a neighbouring ...
IMPORTANT: This information is general financial product advice only and has not taken into account your objectives, financial situation or needs. Consider whether this advice is right for you. You ...
IMPORTANT: This information is general financial product advice only and has not taken into account your objectives, financial situation or needs. Consider whether this advice is right for you. You ...
Hello and welcome to Market Watch for the end of January, and we have now had our binary question, or maybe partly binary question around the inflation rate and whether or not February 18 is actually ...
IMPORTANT: This information is general financial product advice only and has not taken into account your objectives, financial situation or needs. Consider whether this advice is right for you. You ...
While the market is possibly priced for its lowest ever returns despite falling earnings, your portfolio is cheap with nearly 60% of the holdings boasting management with skin in the game reinforced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results